Determination of plasma levels of spirorenone, a new aldosterone antagonist, and one of its metabolites by high-performance liquid chromatography.
A method for the determination of plasma concentrations of spirorenone, a new aldosterone antagonist, and one of its metabolites, chromatographically characterized as 1,2-dihydro-spirorenone, is described. The assay utilizes high-performance liquid chromatography with UV detection. Reproducible results can be obtained with standard deviations of about 5% and the limit of detection is less than 5 ng/ml. Plasma levels of drug and metabolite have been measured after oral doses of 10 and 40 mg, respectively, administered to two male volunteers.